603566 Pulike Biological Engineering,Inc.
- 21.07
- +0.21+1.01%
Pulike Biological Engineering,Inc. News
Placo (603566) 2023 Report & 2024 Quarterly Report Review: Pig Seedling, Chemical and Other Businesses Under Pressure Await Cycle Recovery and Operating Inflection Point
Matters: The company released its 2023 annual report and 2024 quarterly report: achieved revenue of 1,253 million yuan in 2023, yoy +1.84%, net profit of 175 million yuan, yoy +3.99%, deducted from the mother 1
Placo (603566.SH): A total of 1,449,200 shares have been repurchased
Glonghui, May 6, 丨 Placo (603566.SH) announced that as of April 30, 2024, the company had repurchased a total of 1,4492 million shares through centralized bidding transactions, accounting for 0.42% of the company's total share capital. The highest repurchased price was 22.48 yuan/share, the lowest price was 15.47 yuan/share, and the total amount paid was 25,410,025 yuan (excluding transaction fees).
Placo (603566): The pig breeding business is under pressure in the short term, the pig cycle reverses, and the future is bright
Performance summary: In 2023, the company achieved operating income of 1,253 billion yuan, +1.84% year on year; net profit to mother of 175 million yuan, +3.99% year on year; net profit after deduction of 154 million yuan, year-on-year
China Post Securities released a research report on April 28 stating that Placo (603566.SH) was rated to increase its holdings. The main reasons for the rating include: 1) Comments: Pig seedlings are a drag and management efficiency is improved; 2) Produc
China Post Securities released a research report on April 28 stating that Placo (603566.SH) was rated to increase its holdings. The main reasons for the rating include: 1) Comments: Pig seedlings are a drag and management efficiency is improved; 2) Product reserves are abundant, waiting for pet vaccines and non-plague vaccines to be effective. (Mainichi Keizai Shimbun)
What You Need To Know About The Pulike Biological Engineering, Inc. (SHSE:603566) Analyst Downgrade Today
One thing we could say about the analysts on Pulike Biological Engineering, Inc. (SHSE:603566) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forec
Placo (603566): The swine vaccine boom is under pressure and concerns about procyclical performance to release flexibility
Results for 2023 and 1Q24 fell short of our expectations Placo announced 2023 and 1Q24 results: the company achieved revenue of $12.5/235 million in 2023/1Q24, +1.84% YoY /-
China Galaxy released a research report on April 25 stating that Placo (603566.SH) was given a recommended rating. The main reasons for the rating include: 1) the company's revenue & profit increased in 23, putting pressure on 24Q1 performance; 2) revenue
China Galaxy released a research report on April 25 stating that Placo (603566.SH) was given a recommended rating. The main reasons for the rating include: 1) the company's revenue & profit increased in 23, putting pressure on 24Q1 performance; 2) revenue from poultry vaccines and chemicals increased in 23, and the gross margin of pig seedlings increased; 3) adhering to R&D and innovation, the pet sector is expected to develop collaboratively. (Mainichi Keizai Shimbun)
Placo (603566) Company Information Update Report: Performance is expected to reverse and repair with the pig cycle, high dividends highlight investment value
The performance is expected to recover with the reversal of the pig cycle, high dividends highlight investment value, maintain the release of the 2023 annual report and the first quarter report of 2024, and return to revenue of 1,253 billion yuan (+1.84%) in 2023
Placo (603566): Short-term results are under pressure, awaiting industry recovery and new product development
Incident: The company released its 2023 annual report and 2024 quarterly report. Among them, it achieved operating income of 1,253 billion yuan for the full year of 23, an increase of 1.84% over the previous year; net profit to mother was 175 million yuan, an increase of 3.99 million yuan over the previous year
Placo (603566.SH): Net profit of 27.307 million yuan in the first quarter fell 57.36% year on year
On April 25, GLONGHUI (603566.SH) released its first quarter report. Operating revenue was 235 million yuan, down 23.27% year on year, net profit of 27.307 million yuan, down 57.36% year on year, after deducting non-net profit of 265.35,800 yuan, down 56.10% year on year, with basic earnings of 0.08 yuan per share.
Placo (603566): 24Q1 performance is slightly under pressure, and the pet sector is expected to develop collaboratively
Event: The company released its 2023 Annual Report & 2024 First Quarter Report. The company's revenue in '23 was 1,253 billion yuan, +1.84% YoY; net profit to mother was 175 million yuan, +3.99% YoY;
42% Earnings Growth Over 1 Year Has Not Materialized Into Gains for Pulike Biological Engineering (SHSE:603566) Shareholders Over That Period
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if you buy individual stocks, you can do both better or worse than that. Unfortunate
Pulike Biological Engineering, Inc. (SHSE:603566) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
It is hard to get excited after looking at Pulike Biological Engineering's (SHSE:603566) recent performance, when its stock has declined 20% over the past three months. However, stock prices are usu
Zhitong A Share Sale Restriction and Release List | March 19
According to the Zhitong Finance App, the ban on restricted shares of 4 listed companies was lifted on March 19, with a total market value of about 1,316 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, restricted stock type, number of unbanned shares Tang Renshen 002567; original shareholders placed 454.45 million additional A shares; original shareholders placed and listed 1,6795 million Hongyuan Green Energy 603185 equity incentives; limited circulation 2741 million AGCO Technology 68809232.12 million
Placo (603566.SH): The ban on 1.679,500 restricted shares was lifted on March 19
On March 13, GLONGHUI (603566.SH) announced that the total number of shares in circulation in the company's current stock listing was 1.679,500 shares. The stock listing and circulation date is March 19, 2024.
Placo (603566.SH): Plans to invest 120 million yuan to establish a private equity investment fund
On March 12, GLONGHUI (603566.SH) announced that the company signed the “Luoyang Huizhong Hongtai Venture Capital Partnership (Limited Partnership”) with Huizhong Capital, Luoyang Guohong Capital Venture Capital Co., Ltd. (“Luoyang Industrial Development Fund”), and the “Luoyang Huizhong Hongtai Venture Capital Fund Partnership (Limited Partnership)” (“Partnership Agreement”) to jointly fund the establishment of a Luoyang Huizhong Hongtai Venture Capital Fund partnership (limited partnership). The total fund size is 20 million yuan. The company and subsidiary Luoyang Huizhong Private Equity Fund Management Co., Ltd. (referred to as “Huizhong”
Placo (603566.SH): Products under development include bovine, echinococcosis (echinococcosis) vaccines, etc.
GLONGHUI March 4 | Placo (603566.SH) said on the investor interactive platform that currently the company's vaccine for cattle and sheep is the foot-and-mouth disease vaccine, and the products under development include the bovine and sheep echinococcosis (echinococcosis) vaccine.
Placo (603566.SH): The company did not repurchase shares in February
Glonghui March 1 | Placo (603566.SH) announced that in February 2024, the company did not repurchase shares. As of February 29, 2024, the company has repurchased a total of 1,449,200 shares through centralized bidding transactions. The repurchased shares account for 0.42% of the company's total share capital. The highest repurchased price is 22.48 yuan/share, the lowest price is 15.47 yuan/share, and the total amount paid is 25,410,025 yuan.
Express News | Galaxy Securities: Focus on low-level layout opportunities in the pig cycle
Placo (603566.SH): The company is not involved in the financial transfer business
Glonghui, Feb. 19 | Placo (603566.SH) said on the investor interactive platform that the company is not involved in the financial transfer business, and the majority shareholders are not involved in the financial transfer business.
Analysis
Price Target
No Data
